From Innovation to Impact: What Fierce Pharma Week Revealed About the Future of Healthcare Marketing

Healthcare marketers have no shortage of tools, data or channels available to them. But a persistent challenge they face is ensuring that those resources are helping patients and healthcare professionals get what they need in a way that’s measurable.

This challenge was at the crux of what industry professionals discussed at Fierce Pharma Week 2026. Across conversations about artificial intelligence, content, measurement and Point of Care (POC), marketers debated how to translate investment into useful experiences and meaningful action.

To explore what surfaced at this year’s event, POCMA spoke with Stephanie Butler, Senior Conference Production Director at Fierce Life Sciences, whose work includes developing the conference’s content.

Why Attend Fierce Pharma Week? The Event Brings the Healthcare Marketing Ecosystem Into One Conversation

Fierce Pharma Week brings together four professional communities: pharma marketing, medical affairs, commercialization, and PR and communications. Its in-person program combines education and networking, creating opportunities to explore challenges across functions as well as within them. This year’s event included 14 specialized content tracks and more than 490 industry speakers.

For marketers, the value of that gathering goes beyond discovering a new campaign idea. It allows them to engage in dialogue with other industry professionals who shape the patient journey, because a patient’s experience can be shaped by decisions made across multiple teams, even when those teams operate with different priorities and measures of success.

“[Different teams within a pharmaceutical brand may be looking at issues differently], but ultimately everyone has to work together to get to the same end goal, right?” Butler said.

Attending creates an opportunity to examine those differences directly. What does medical need to establish credibility? What does commercialization need to support access? What does marketing need to help people act on information? Understanding those perspectives can make collaboration more productive once attendees return to their organizations.

There’s also value in comparing experiences directly with peers.

“[Attending Fierce Pharma Week allows marketers to] have actual conversations with human beings about what's working and what doesn't work,” Butler said.

For pharma marketers considering attendance, the attendee mix across disciplines offers a reason to look beyond sessions aligned with their immediate responsibilities. A conversation in another discipline, for example, may expose an assumption, an unmet need or an organizational barrier that a marketing-only discussion would miss.

Here are the themes that Stephanie surfaced from this year’s event that are relevant for marketers building patient-centric 2027 media plans.

Key Themes & Takeaways from Fierce Pharma Week 2026

AI & Technology Need a Defined Job

One hot topic at Fierce Pharma Week 2026 was technology and how healthcare marketers can use it to enhance the patient and provider experience.

Healthcare marketers have access to more technology than ever, but “technology in and of itself is not a solution to your challenges,” Butler said when asked about her learnings from this year’s conference.

The most obvious driver of new technology investment in healthcare is Artificial Intelligence (AI). But the adoption of AI within the healthcare industry presents marketers with an increasingly practical decision: which problem should it help solve?

“Don't just think of [AI] as a shiny new toy that you need to have because it's a shiny new toy. Figure out what the problem is first, then figure out what the solution is and [THEN] AI may be [able to help you solve for that],” Butler said.

That sequence matters. Starting with a tool can produce an impressive demonstration without establishing whether it addresses the underlying need. But starting with the problem you’re trying to solve creates a clearer basis for evaluating tools, their use and the results they deliver.

Consider a team trying to get useful educational content into market faster. Before selecting technology to help them accelerate time to market, it should identify where the delay occurs. Is the challenge developing the material, coordinating feedback, adapting approved assets or deciding who owns the next step? Answering these questions will help marketers identify the right place where technology can help them augment their efforts.

The same thinking applies to audience targeting and analytics. More sophisticated targeting and analytics tools cannot substitute for a clear objective or confidence in the information being processed.

The implication for marketers is straightforward: evaluate technology by the value it can bring to a particular care moment. A capability should help teams deliver relevant information or support a useful next step. Its novelty alone is not a reason to invest.

Content Strategy Must Survive Execution

Another persistent conversation at Fierce focused on content, arguably the most critical component of any healthcare marketing strategy.

The prevailing sentiment? A strong go-to-market strategy has limited value if the organization cannot deliver the content it requires at the right moments.

“[Organizations] have strong content strategies, but then they struggle to create it, approve it, adapt it [and] reuse it at the speed that the business actually needs them to do it,” Butler said.

This is a planning issue as much as a production issue. Audience needs, formats, review responsibilities and opportunities for reuse should be considered while the strategy is being built. Otherwise, teams risk discovering too late that the content they need cannot move through the organization quickly enough.

The practical takeaway is to connect content strategy to delivery from the outset. Identify what each audience needs, where it will encounter the material, and what must happen internally to make that experience possible.

Trust Starts With the Experience People Actually Have

The usefulness of healthcare content and communications also depends on whether it addresses what people need from healthcare.

“[Healthcare brands should] build better community engagement. Build that relationship - give us what we need, not what you want us to have,” Butler advised.

For marketers, that is a demanding test of relevance. A brand may want to communicate a treatment benefit while a patient is trying to understand how to afford treatment. A team may want to distribute more educational content while a provider needs a concise answer during a busy visit.

These needs should influence both the message and its placement. The goal should be to make information usable within the experience people are already having.

Measurement Must Explain What Changed

In addition to discussions on emerging technology, marketing strategy and content, Fierce Pharma Week attendees explored how they could effectively measure the impact of their go-to-market efforts once their campaigns had wrapped.

The headline? Effective measurement requires agreement on what success means before activity begins.

“Engagement itself can't be the end result [of a campaign] anymore,” Butler said.

Reach and engagement can provide useful signals. But the strategic question marketers need to ask is how those signals connect to the objective a campaign was designed to support. A large number of exposures does not, on its own, explain whether an audience became better prepared, took a relevant action or encountered fewer barriers to care.

For POC marketers, for example, the intended result might involve kickstarting a treatment conversation, referral, treatment initiation or another defined action. The appropriate measure will depend on the campaign’s purpose and what can credibly be evaluated. Establishing that purpose early helps teams distinguish delivery metrics from evidence of impact.

It also creates room to learn from efforts that fall short.

“[When measuring your efforts], seeing what's a success is useful, but seeing what didn't work is equally as useful,” Butler said.

For marketers under pressure to justify investment, that learning is valuable. A measurement plan should help the organization make better choices, including recognizing when a different approach is needed.

Point of Care: Useful Information in the Moments That Matter

For POCMA, one of the most insightful parts of our conversation with Stephanie concerned the place of Point of Care in the wider industry conversation at Fierce Pharma Week.

Asked about POC’s presence at the conference, Butler said: “[POC has] definitely become more of a discussion as part of this event.”

“[POC is] not just a tactic. [Successfully leveraging POC requires you to ask] how you can actually be useful to [patients and providers] in that exact moment,” she said.

That is an important standard for evaluating a POC investment. Being present in a healthcare setting creates an opportunity; making the communication useful requires understanding what is happening there. Who is involved? What question needs an answer? What decision or next step can the information support?

“[Patients and providers] don't need more information. They need the right information. So how do you fit into what they're doing at that moment?” Butler asked.

For marketers, that means considering the full care team and the different needs that emerge across a patient’s experience. A physician, nurse, pharmacist and patient may all need information related to the same treatment, but the communication should reflect their roles and circumstances.

It also means looking carefully at workflow. A message that interrupts a task without helping complete it can create friction. A message designed around an existing information need has a clearer purpose.

The planning implication extends across POC settings. Marketers should assess where their communication can help someone understand an option, prepare a question or take a next step. That requires connecting patient and HCP strategies around the care experience rather than developing each in isolation.

Looking Ahead to Fierce Pharma Week 2027

So what’s in store for Fierce Pharma Week 2027? The next event offers an opportunity to examine how the priorities attendees this year discussed develop further.

In the interview, Butler discussed areas she would like to explore in future; On the role of marketing, Butler said: “[Marketing’s] role and their function is fundamentally changing, and that's not just in conjunction with technology but also in conjunction with what [they’re accountable for delivering].”

“I would [also] like to talk more about how the healthcare ecosystem is changing,” Butler said.

For marketers considering next year’s event, the opportunity is to return to these questions with practical experience: what’s been implemented in the past year, what’s been learned, and what still needs to change?

Butler also wanted to go deeper on the conversation about marketing channels.

“Omnichannel doesn't have to be all channels at all times for all information in all ways,” Butler said.

That is a useful principle for 2027 planning. A marketer’s objective is to choose channels deliberately, with a clear understanding of the role each can play and how the experience connects for patients and healthcare professionals.

Ultimately, all of these efforts should be in service of care needs and the interactions where information can support action. So the starting point should always be understanding the person, then designing the plan around what will help them.

Visit Fierce Pharma Week for further updates on the event, and explore POCMA’s resources to inform your next Point of Care plan.